No standard treatment is available for advanced pancreatic cancer

European Journal of Cancer

Volumn 31, Issue 6, 1995, Pages 882-887

  Lionetto, R ^a   Pugliese, V ^a   Bruzzi, P ^a   Rosso, R ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

drug therapy; pancreatic neoplasms; radiotherapy; random allocation; randomised controlled trial; review article; therapy

Indexed keywords

AMINOGLUTETHIMIDE; AZIRIDINYLBENZOQUINONE; CAFFEINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DIHYDROXYANTHRACENEDIONE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; GOSERELIN; LOMUSTINE; METHOTREXATE; MITOGUAZONE; MITOMYCIN C; SEMUSTINE; STREPTOZOCIN; TAMOXIFEN; TEGAFUR; VINCRISTINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; META ANALYSIS; PANCREAS CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; CLINICAL TRIALS, PHASE III; HUMANS; MIDDLE AGED; PANCREATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS;

EID: 0029040131     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(94)00445-5     Document Type: Article

References (43)

1. Cancer of the pancreas
2. Non surgical management
3. Treatment of pancreatic carcinoma therapeutic nihilism?
4. Current status of chemotherapy for advanced pancreatic and gastric cancer
5. Cancer of the pancreas. 50 years of surgery
6. La chimiotherapie du cancer du pancreas exocrine
7. Le traitment des cancers du pancreas exocrine
8. Combined radiotherapy and chemotherapy in the treatment of gastrointestinal malignancies
9. Chemotherapy for pancreatic cancer
10. A method for assessing the quality of a randomized control trial
11. Statistical guidelines for contributors to medical journals
12. Use of check list in assessing the statistical content of medical studies
13. Publication bias and clinical trials
14. Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma
15. Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma
16. Comparison of single-agent epirubicin and 5-fluorouracil/epirubicin/mitomycin in patients with advanced adenocarcinoma of the pancreas
17. Hormonal treatment of unresectable pancreatic cancer with LHRH analogue (goserelin)
18. Treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin (luteinizing hormone-releasing hormone)
19. A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma
20. Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas
21. Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of Vater
22. A phase III trial on the therapy of advanced pancreatic carcinoma
23. FAM chemotherapy ± aminoglutethimide in the treatment of pancreatic carcinoma
24. A prospective randomized controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma
25. Phase II studies of drug combinations in advanced pancreatic carcinoma fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil
26. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM)
27. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin
28. Treatment of unresectable pancreatic carcinoma with 5-fluorouracil vincristine and CCNU
29. Randomized trial of F-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer
30. Trials of single agent and combination chemotherapy for advanced cancer of the pancreas
31. A phase III study of adriamycin + 5FU vs. BCNU + adriamycin + ftorafur for patients with advanced pancreatic cancer
32. Randomized study of 5-FU and CCNU in pancreatic cancer: report of the Veterans Administration Surgical Adjuvant Cancer Chemotherapy Study Group
33. A controlled trial of combination chemotherapy with 5-FU and BCNU in pancreatic cancer
34. Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomized, multicentre trial
35. A randomized trial of intraoperative radiation therapy (IORT) vs IORT plus chemotherapy (MTX-5FU) for adenocarcinoma of the pancreas
36. Treatment of locally unresectable carcinoma of the pancreas comparison of combined modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone
37. Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma
38. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil. An Eastern Cooperative Oncology Group Study
39. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rad) radiation alone, moderate dose radiation (4000 rad + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The Gastrointestinal Tumor Study Group
40. 5-Fluorouracil, methyl-CCNU, and radiotherapy with or without testolactone for localized adenocarcinoma of the exocrine pancreas. A Southwest Oncology Group study
41. Cancer mortality in Italy: an overview of age-specific and age-standardized trends from 1955 to 1985
42. Design and analysis of randomized clinical trials requiring prolonged observation of each patient